A CELLULAR PROTEIN MEDIATES ASSOCIATION OF P53 WITH THE E6 ONCOPROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 OR TYPE-18

被引:705
作者
HUIBREGTSE, JM
SCHEFFNER, M
HOWLEY, PM
机构
[1] Lab of Tumor Virus Biology, National Cancer Institute, Bethesda
关键词
HUMAN PAPILLOMAVIRUS; HPV E6; P53; UBIQUITIN-DEPENDENT PROTEOLYSIS; VIRAL ONCOPROTEIN;
D O I
10.1002/j.1460-2075.1991.tb04990.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.
引用
收藏
页码:4129 / 4135
页数:7
相关论文
共 50 条
[31]   A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis [J].
Takafumi Nakamura ;
Lisa Williams-Simons ;
Heiner Westphal .
Oncogene, 1997, 14 :2991-2998
[32]   E6-Associated Protein Is Required for Human Papillomavirus Type 16 E6 to Cause Cervical Cancer in Mice [J].
Shai, Anny ;
Pitot, Henry C. ;
Lambert, Paul F. .
CANCER RESEARCH, 2010, 70 (12) :5064-5073
[33]   A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis [J].
Nakamura, T ;
WilliamsSimons, L ;
Westphal, H .
ONCOGENE, 1997, 14 (25) :2991-2998
[34]   Suppression of senescence in normal human fibroblasts by introduction of dominant-negative p53 mutants or human papilloma virus type 16 E6 protein [J].
Ide, A ;
Fujii, M ;
Nakababashi, K ;
Ayusawa, D .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1998, 62 (07) :1458-1460
[35]   The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints [J].
Thompson, DA ;
Belinsky, G ;
Chang, THT ;
Jones, DL ;
Schlegel, R ;
Münger, K .
ONCOGENE, 1997, 15 (25) :3025-3035
[36]   The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints [J].
David A Thompson ;
Glenn Belinsky ;
Ted H-T Chang ;
D Leanne Jones ;
Robert Schlegel ;
Karl Münger .
Oncogene, 1997, 15 :3025-3035
[37]   Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway [J].
C L Au Yeung ;
T Y Tsang ;
P L Yau ;
T T Kwok .
Oncogene, 2011, 30 :2401-2410
[38]   Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins [J].
Park, JS ;
Kim, EJ ;
Lee, JY ;
Sin, HS ;
Namkoong, SE ;
Um, SJ .
INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (06) :822-827
[39]   Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer [J].
Tung, Min-Che ;
Wu, Heng-Hsiung ;
Cheng, Ya-Wen ;
Wang, Lee ;
Chen, Chih-Yi ;
Yeh, Sauh-Der ;
Wu, Tzu-Chin ;
Lee, Huei .
CANCER, 2013, 119 (18) :3367-3376
[40]   Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway [J].
Yeung, C. L. Au ;
Tsang, T. Y. ;
Yau, P. L. ;
Kwok, T. T. .
ONCOGENE, 2011, 30 (21) :2401-2410